Skip to main content

Table 2 Outcomes of patients in high-volume haemofiltration and control groups

From: Early application of continuous high-volume haemofiltration can reduce sepsis and improve the prognosis of patients with severe burns

  Burn ≥ 50% TBSA Burn ≥ 80% TBSA
Control (n = 41) HVHF (n = 41) p Value Control (n = 21) HVHF (n = 17) p Value
Mortality
 28-day, n (%) 13 (31.7) 9 (22.0) 0.46 10 (47.6) 5 (29.4) 0.33
 60-day, n (%) 17 (41.5) 11 (26.8) 0.24 13 (61.9) 5 (29.4) 0.06
 90-day, n (%) 19 (46.3) 11 (26.8) 0.11 14 (66.7) 5 (29.4)a 0.049
Sepsis, n (%) 21 (51.2) 11 (26.8)a 0.04 15 (71.4) 6 (37.5)a 0.04
Septic shock, n (%) 18 (43.9) 6 (14.6)a 0.01 13 (61.9) 3 (18.6)a 0.01
Duration of MV (days) 8.5 (5.3, 11.8) 7.0 (4.0, 10.5) 0.19 9.5 (2.5, 16.3) 7.0 (2.0, 8.0) 0.09
ICU days 28.5 (20.0, 48.0) 34.5 (15.5, 55.0) 0.84 31.0 (21.5, 47.5) 49.0 (18.0, 67.0) 0.23
Duration of vasopressors (days) 4.0 (2.0, 11.0) 1.0 (1.0, 1.0)a 0.001 8.0 (2.0, 12.5) 1.5 (1.0, 2.8)a 0.04
  1. Abbreviations: TBSA Total burn surface area, MV Mechanical ventilation, ICU Intensive care unit, HVHF High-volume haemofiltration
  2. Data are presented as medians (25th and 75th quantiles) or percentages. All patients were included in outcome comparisons via the intention-to-treat principle
  3. a p < 0.05 indicates a significant difference compared with the control group